AROMASIN is indicated for adjuvant treatment of postmenopausal Women of all ages with estrogen-receptor optimistic early breast most cancers who may have been given two to a few yrs of tamoxifen and therefore are switched to AROMASIN for completion of a total of five consecutive years of adjuvant hormonal therapy [see Clinical Scientific tests (fou